Urologic Oncology Seminars and Original Investigations · 2019 · 46 citations · 29 references
MedicineOncologySurgeryMolecular OncologyOncologic SurgerySurgical OncologyCancer Survival AnalysisMalignant NeoplasmsMolecular Classification Of TumorsMolecular Tumor ProfilingRadical CystectomyTumor ClassificationCancer Prognostic ModelingCancer Subtype DiscoveryCystectomy RecurrenceDisease-specific SurvivalMolecular Subtype PredictionSubtype Prognosis ModelingVariant Interpretation In Oncology
29
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
Sanjeev Mariathasan, Shannon J. Turley, Dorothee Nickles et al. · Nature · 2018 · 5.5K citations
Life Sciences, Immunology, Oncology +16
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
Joaquim Bellmunt, Ronald de Wit, David J. Vaughn et al. · New England Journal of Medicine · 2017 · 3.4K citations · Full text
Medicine, Oncology, Pharmacology +17
Comprehensive molecular characterization of urothelial bladder carcinoma
Zhenlin Ju · Nature · 2014 · 3.1K citations · Full text
Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer
A. Gordon Robertson, Jaegil Kim, Hikmat Al‐Ahmadie et al. · Cell · 2017 · 2.5K citations · Full text